| Quan, Stuart |
| Completed | N/A | 115 | US | Sleep Extension, Routine | University of Arizona | Type 1 Diabetes | 03/24 | 06/24 | | |
| Armstrong, David |
COVER DFUs, NCT05372809: Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs |
|
|
| Terminated | 3 | 42 | US | SkinTE, Autologous Heterogeneous Skin Construct, Control, Standard of Care | PolarityTE, Alira Health | Diabetic Foot | 02/24 | 02/24 | | |
NCT04267640: Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers |
|
|
| Recruiting | 2 | 60 | US | AMG0001, HGF plasmid, Collategene, beperminogene perplasmid, Placebo | AnGes USA, Inc. | Peripheral Artery Disease, Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease, Chronic Limb Threatening Ischemia, Ischemic Ulcer of Foot | 07/22 | 01/23 | | |
NCT03754465: Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers |
|
|
| Active, not recruiting | 2 | 56 | US | ALLO-ASC-DFU, Hydrogel sheet containing Allogenic Mesenchymal Stem Cells, Hydrogel SHEET(Vehicle control), Hydrogel sheet without Allogenic Mesenchymal Stem Cells | Anterogen Co., Ltd. | Diabetic Foot Ulcer | 11/23 | 05/24 | | |
NCT04497805: Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers |
|
|
| Recruiting | 2 | 64 | US | ALLO-ASC-SHEET, Hydrogel sheet containing Allogenic Mesenchymal Stem Cells | Anterogen Co., Ltd. | Diabetic Foot Ulcer | 12/24 | 06/25 | | |
| Recruiting | 2 | 210 | US | Boot | University of Southern California, Baylor College of Medicine | Diabetic Foot Ulcer | 12/25 | 12/25 | | |
| Recruiting | N/A | 30 | Canada | Colonoscopy | McMaster University | Crohn's Disease of Both Small and Large Intestine | 01/25 | 01/25 | | |
NCT03855514: Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers |
|
|
| Recruiting | N/A | 200 | US | NuShield | Organogenesis | Diabetic Foot Ulcer | 11/21 | 12/21 | | |
BGWM, NCT06403605: Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers |
|
|
| Recruiting | N/A | 100 | US | Mirragen Wound Matrix, Fibracol | ETS Wound Care, LLC, Professional Education and Research Institute | Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot | 12/24 | 12/24 | | |
| Terminated | N/A | 8 | US | Pulsed splenic ultrasound, Active ultrasound, Ultrasound probe (no energy applied) | General Electric Research | Burn Wound, 2nd Degree Burn of the Skin | 12/24 | 12/24 | | |
NCT05797285: Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers |
|
|
| Completed | N/A | 26 | US | human keratin graft, ProgenaMatrix | ProgenaCare Global, LLC, Professional Education and Research Institute | Ulcer Healing, Diabetic Foot Ulcer | 12/23 | 12/23 | | |
NCT04564443: A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot |
|
|
| Active, not recruiting | N/A | 222 | US | Medaxis Debritom+, Sharp Surgical Debridement, Additional Outer Dressing Application, Offloading, Pressure Relief, Fibracol Wound Dressing, Calcium Alginate | Medaxis, LLC, Professional Education and Research Institute | Diabetic Foot Ulcer, Diabetic Foot | 12/24 | 12/24 | | |
NCT06035523: Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™ |
|
|
| Recruiting | N/A | 50 | US | Endoform™ Antibacterial, Endoform™ Natural, Symphony™ | Aroa Biosurgery Limited, Professional Education and Research Institute | Wound Healing, Diabetic Foot, Chronic Foot Ulcer, Foot Ulcer | 06/24 | 06/24 | | |
| Recruiting | N/A | 60 | Canada | low FODMAP diet, Lactose Sachet, Fructose Sachet, Sorbitol Sachet, Inulin Sachet, AIRE-2 Portable breath analyzer | McMaster University | Inflammatory Bowel Diseases | 09/27 | 12/27 | | |
| Recruiting | N/A | 50 | Canada | L-Tryptophan, Freedom SimpleCap Powder | McMaster University | Tryptophan Metabolism Alterations, Celiac Disease | 04/25 | 06/25 | | |
NCT06681428: Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers |
|
|
| Recruiting | N/A | 240 | US | Allograft | Tides Medical, Professional Education and Research Institute | Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers | 11/26 | 11/26 | | |
NCT06035536: Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers |
|
|
| Recruiting | N/A | 120 | US | Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol | Aroa Biosurgery Limited, Professional Education and Research Institute | Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer | 12/24 | 12/24 | | |
| Not yet recruiting | N/A | 45 | Canada | Intermittent Fasting Intervention, Mediterranean Diet Intervention, Low FODMAP Diet Intervention | McMaster University | IBD (Inflammatory Bowel Disease), Ulcerative Colitis (UC), Crohn Disease (CD) | 01/26 | 01/27 | | |
NCT06104969: DFC 004 Biomarkers for Active Diabetic Foot Ulcers |
|
|
| Recruiting | N/A | 5000 | US | | University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetic Foot Ulcer, Diabetic Foot, Diabetes | 06/28 | 06/28 | | |
| Recruiting | N/A | 1000 | Canada | | University Health Network, Toronto, Canadian Nutrition Society, Baxter Healthcare Corporation, Ontario Medical Supply | Parenteral Nutrition, Home | 12/29 | 12/29 | | |
| Daines, Cori |
NCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection |
|
|
| Recruiting | 1/2 | 72 | US, RoW | RSP-1502, Tobramycin inhalation solution | Respirion Pharmaceuticals Pty Ltd | Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa | 12/25 | 12/25 | | |
| Recruiting | N/A | 430 | Canada, US | Immediate Oral Antibiotics, Tailored Treatment: Oral Antibiotics only if Additional Treatment needed | University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation | Cystic Fibrosis | 12/27 | 02/29 | | |
NCT05639556: Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF |
|
|
| Recruiting | N/A | 300 | US | BMI and lean mass index from DXA, Anthropometric Measurements, Hand-grip strength, Six-minute walk Test, Sit-to-Stand Test, Short physical performance battery (SPPB), BIA Sub-study, Accelerometry to assess physical activity, Gastrointestinal (GI) and nutrition questionnaires:, Psychosocial questionnaire: PHQ-8, Psychosocial questionnaire: GAD-7, Psychosocial questionnaire: The Treatment Self-Regulation Questionnaire (TSRQ), Psychosocial questionnaire: CF Fatalism Scale, Psychosocial questionnaire: Body Esteem Scale for Adolescents and Adults (BESAA), 12-month Questionnaire, Oral glucose tolerance testing (OGTT), Continuous glucose monitoring (CGM), Chest CT scans (When available within the past 6 months in medical records), Hologic Dual X-Ray Absorptiometry (DXA), Ultrasound Sub-study of assessment of appendage muscles using ultrasound, Psychosocial questionnaire: Hunger Vital Sign questionnaire, Respiratory symptom questionnaire: CRISS, Spirometry, Psychosocial questionnaire: Additional Health Questionnaire | Jaeb Center for Health Research | Cystic Fibrosis | 12/28 | 12/28 | | |
| Parthasarathy, Sairam |
| Completed | 4 | 155 | US | Zolpidem, Ambien, Internet Cognitive Behavioral Therapy for Insomnia (CBT-I), SHUTi, Trazodone, Desyrel | California Pacific Medical Center Research Institute, Patient-Centered Outcomes Research Institute, University of Pittsburgh, University of Arizona, University of Virginia, University of Illinois at Chicago | Chronic Insomnia | 06/24 | 06/24 | | |
NCT04778059: Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 |
|
|
| Terminated | 2 | 21 | US | USB002, Placebo | US Biotest, Inc. | 2019 Novel Coronavirus Infection, COVID-19 Virus Infection, SARS Coronavirus 2 Infection, SARS-CoV-2 Infection, Respiratory Distress Syndrome, Adult, Adult Respiratory Distress Syndrome | 05/22 | 05/22 | | |
| Active, not recruiting | 2 | 964 | US | Experimental: Paxlovid 25 day dosing, Experimental: Paxlovid 15 day dosing, Placebo Comparator: Control | Kanecia Obie Zimmerman | Long COVID, Long Covid19 | 08/24 | 03/25 | | |
| Active, not recruiting | N/A | 900 | US | aerSleep II | Sommetrics, Inc. | Sleep Apnea, Obstructive, Apnea, Sleep | 12/25 | 12/25 | | |
| Rodriguez, Osmara Y Molina de |
| No trials found |
